A Study to Test How Different Doses of BI 765423 Are Taken up in the Body of Healthy Men
NCT05658107 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2024-04-03
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 765423 in healthy male subjects following intravenous administration of single rising doses.
Conditions
- Healthy
Interventions
- DRUG
-
BI 765423
BI 765423
- DRUG
-
Placebo
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-16
- Primary Completion
- 2024-03-19
- Completion
- 2024-03-19
Countries
- Belgium
Study Locations
More Related Trials
-
A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated
NCT06081530 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests the Safety, Tolerability and How Different Doses of BI 1265162 Are Taken up in the Body of Healthy Men
NCT03349723 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers.
NCT01650155 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers
NCT01348165 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers
NCT02244203 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers
NCT03175211 ·Status: COMPLETED ·Phase: PHASE1
-
This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated.
NCT03588390 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043
NCT04789304 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess Safety, Tolerability and Pharmacokinetics of BI 443651 in Healthy Male Volunteers
NCT02706925 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated
NCT03747926 ·Status: WITHDRAWN ·Phase: PHASE1
-
Single Rising Oral Doses of BI 10773 in Healthy Male Volunteers
NCT02182453 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated
NCT04978506 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men
NCT06006598 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated
NCT04958252 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0003)
NCT05934955 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated
NCT04665700 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated
NCT03793621 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1584862 Are Tolerated
NCT06148948 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT04866160 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers
NCT01958060 ·Status: TERMINATED ·Phase: PHASE1
-
Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers
NCT01638598 ·Status: COMPLETED ·Phase: PHASE1
-
A Study About How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated in Healthy Japanese Men
NCT03875001 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers
NCT02183545 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male Volunteers
NCT02852824 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated
NCT05183360 ·Status: TERMINATED ·Phase: PHASE1